Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer - Fig 1

<p><b>Receiver operating characteristic curves for pretreatment plasma fibrinogen predicting overall survival (A), and recurrence-free survival (B).</b> Using ROC curve analysis, a pretreatment plasma fibrinogen cutoff value of 447mg/dL was determined for both OS and RFS.</p

Kaplan–Meier estimates of the probability of overall survival in 183 patients with locally advanced OOSCC according to low and high pretreatment plasma fibrinogen.

<p>Kaplan–Meier estimates of the probability of overall survival in 183 patients with locally advanced OOSCC according to low and high pretreatment plasma fibrinogen.</p

Kaplan–Meier estimates of the probability of recurrence-free survival in 183 patients with locally advanced OOSCC according to low and high pretreatment plasma fibrinogen.

<p>Kaplan–Meier estimates of the probability of recurrence-free survival in 183 patients with locally advanced OOSCC according to low and high pretreatment plasma fibrinogen.</p

Correlation between pretreatment plasma fibrinogen levels and clinicopathological parameters in 183 patients with oral and oropharyngeal cancer.

<p>Correlation between pretreatment plasma fibrinogen levels and clinicopathological parameters in 183 patients with oral and oropharyngeal cancer.</p

Univariate and multivariate analysis of prognostic factors for overall survival and recurrence-free survival in patients with oral and oropharyngeal cancer.

<p>Univariate and multivariate analysis of prognostic factors for overall survival and recurrence-free survival in patients with oral and oropharyngeal cancer.</p